Solutions OP Clinical Trials UK

by Olga Peycheva

This podcast is dedicated to clinical trials and clinical research. We will be discussing different hot topics and analysis of the latest developments in clinical trials in pharmaceutical and medical devices industries.

Management
Medicine
Listen on ...

Podcast episodes

  • Digital Therapeutics Trends And Expectations

    Digital Therapeutics Trends And Expectations

    E17
    15:25

    The latest episode is about digital therapeutics and what can we expect from them in the future. There is also a discussion on the latest report from MHRA on mental health digital therapeutics and the feedback from users and specialists.

  • How Biosecurity Regulations Could Affect Clinical Research?

    How Biosecurity Regulations Could Affect Clinical Research?

    E16
    16:49

    This episode is an analysis of the changing genomic data regulations and some upcoming biosecurity regulations and how they could affect clinical research. It covers the following regions: China, USA, UK and the EU.

  • Clinical Trials: The UK Budget And Contracts Process

    Clinical Trials: The UK Budget And Contracts Process

    E15
    18:09

    This episode is dedicated to the budget and contract process for clinical trials in the UK. The main topic is what is the current process, what works and what doesn't and how we can improve it.

  • Clinical Trials - Failure By Protocol Design

    Clinical Trials - Failure By Protocol Design

    E14
    16:13

    Can a clinical trial fail because of poor protocol design? You can learn the answer in this episode which reviews a real life case of a clinical trial which failed because of its protocol design.

  • The Challenges And Benefits Of Involving Patients In Industry Sponsored Research

    The Challenges And Benefits Of Involving Patients In Industry Sponsored Research

    E13
    23:54

    This episode is about patients' involvement in clinical trials and the challenges and benefits for the industry of involving patients in the study design and review of patient facing materials. While it is easy to engage patients in academic and social research, there are some unique challenges for pharma and biotech companies.